12 0 2 0 2 O
- 2 3 2 3 O
lead 3 7 3 7 O
electrocardiogram 8 25 8 25 B-clinical_variable
( 26 27 26 27 I-clinical_variable
ECG 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
conducted 32 41 32 41 O
at 42 44 42 44 O
the 45 48 45 48 O
screening 49 58 49 58 O
visit 59 64 59 64 O
within 65 71 65 71 O
normal 72 78 72 78 O
limits 79 85 79 85 O
or 86 88 86 88 O
abnormal 89 97 89 97 O
but 98 101 98 101 O
not 102 105 102 105 O
clinically 106 116 106 116 O
significant 117 128 117 128 O
to 129 131 129 131 O
the 132 135 132 135 O
Investigator 136 148 136 148 O

Able 0 4 149 153 O
to 5 7 154 156 O
continue 8 16 157 165 O
the 17 20 166 169 O
following 21 30 170 179 O
medications 31 42 180 191 B-treatment
without 43 50 192 199 O
a 51 52 200 201 O
significant 53 64 202 213 O
adjustment 65 75 214 224 O
of 76 78 225 227 O
dosage 79 85 228 234 O
, 85 86 234 235 O
formulation 87 98 236 247 O
, 98 99 247 248 O
dosing 100 106 249 255 O
interval 107 115 256 264 O
for 116 119 265 268 O
the 120 123 269 272 O
duration 124 132 273 281 O
of 133 135 282 284 O
the 136 139 285 288 O
study 140 145 289 294 O

Able 0 4 295 299 O
to 5 7 300 302 O
inhale 8 14 303 309 O
study 15 20 310 315 B-treatment
drug 21 25 316 320 I-treatment
properly 26 34 321 329 O

Able 0 4 330 334 O
to 5 7 335 337 O
replace 8 15 338 345 O
current 16 23 346 353 O
regularly 24 33 354 363 O
scheduled 34 43 364 373 O
SABAs 44 49 374 379 B-treatment
with 50 54 380 384 O
albuterol 55 64 385 394 B-treatment
/ 64 65 394 395 I-treatment
salbutamol 65 75 395 405 I-treatment
inhaler 76 83 406 413 I-treatment
for 84 87 414 417 O
use 88 91 418 421 O
only 92 96 422 426 O
on 97 99 427 429 O
as 100 102 430 432 O
needed 103 109 433 439 O
basis 110 115 440 445 O
for 116 119 446 449 O
the 120 123 450 453 O
duration 124 132 454 462 O
of 133 135 463 465 O
the 136 139 466 469 O
study 140 145 470 475 O

Adolescent 0 10 476 486 O
and 11 14 487 490 O
adult 15 20 491 496 O
male 21 25 497 501 B-gender
or 26 28 502 504 I-gender
female 29 35 505 511 I-gender
patients 36 44 512 520 I-gender

Anti 0 4 521 525 B-treatment
- 4 5 525 526 I-treatment
IgE 5 8 526 529 I-treatment
( 9 10 530 531 O
such 10 14 531 535 O
as 15 17 536 538 O
omalizumab 18 28 539 549 B-treatment
) 28 29 549 550 O
within 30 36 551 557 O
the 37 40 558 561 O
6 41 42 562 563 B-upper_bound
months 43 49 564 570 I-upper_bound
prior 50 55 571 576 I-upper_bound
to 56 58 577 579 O
screening 59 68 580 589 O

Any 0 3 590 593 O
other 4 9 594 599 O
clinically 10 20 600 610 O
significant 21 32 611 622 O
pulmonary 33 42 623 632 B-chronic_disease
disease 43 50 633 640 I-chronic_disease
except 51 57 641 647 O
for 58 61 648 651 O
asthma 62 68 652 658 B-chronic_disease
, 68 69 658 659 O
including 70 79 660 669 O
chronic 80 87 670 677 B-chronic_disease
obstructive 88 99 678 689 I-chronic_disease
pulmonary 100 109 690 699 I-chronic_disease
disease 110 117 700 707 I-chronic_disease
( 118 119 708 709 I-chronic_disease
COPD 119 123 709 713 I-chronic_disease
) 123 124 713 714 I-chronic_disease
, 124 125 714 715 O
interstitial 126 138 716 728 B-chronic_disease
lung 139 143 729 733 I-chronic_disease
disease 144 151 734 741 I-chronic_disease
, 151 152 741 742 O
cystic 153 159 743 749 B-chronic_disease
fibrosis 160 168 750 758 I-chronic_disease
, 168 169 758 759 O
bronchiectasis 170 184 760 774 B-chronic_disease
, 184 185 774 775 O
chronic 186 193 776 783 B-chronic_disease
bronchitis 194 204 784 794 I-chronic_disease
, 204 205 794 795 O
emphysema 206 215 796 805 B-chronic_disease
, 215 216 805 806 O
active 217 223 807 813 B-chronic_disease
pulmonary 224 233 814 823 I-chronic_disease
tuberculosis 234 246 824 836 I-chronic_disease
, 246 247 836 837 O
pulmonary 248 257 838 847 B-cancer
carcinoma 258 267 848 857 I-cancer
, 267 268 857 858 O
pulmonary 269 278 859 868 B-chronic_disease
fibrosis 279 287 869 877 I-chronic_disease
, 287 288 877 878 O
or 289 291 879 881 O
pulmonary 292 301 882 891 B-chronic_disease
hypertension 302 314 892 904 I-chronic_disease

Baseline 0 8 905 913 O
pre 9 12 914 917 O
bronchodilator 13 27 918 932 O
FEV1 28 32 933 937 B-clinical_variable
should 33 39 938 944 O
be 40 42 945 947 O
≥45 43 46 948 951 O
% 46 47 951 952 I-lower_bound
and 48 51 953 956 O
≤85 52 55 957 960 O
% 55 56 960 961 I-upper_bound
of 57 59 962 964 O
predicted 60 69 965 974 O
normal 70 76 975 981 O
value 77 82 982 987 O
and 83 86 988 991 O
not 87 90 992 995 O
vary 91 95 996 1000 O
by 96 98 1001 1003 O
more 99 103 1004 1008 O
than 104 108 1009 1013 O
±20 109 112 1014 1017 O
% 112 113 1017 1018 I-lower_bound
from 114 118 1019 1023 O
the 119 122 1024 1027 O
screening 123 132 1028 1037 O
visit 133 138 1038 1043 O
FEV1 139 143 1044 1048 O
value 144 149 1049 1054 O

Body 0 4 1055 1059 B-bmi
mass 5 9 1060 1064 I-bmi
index 10 15 1065 1070 I-bmi
( 16 17 1071 1072 I-bmi
BMI 17 20 1072 1075 I-bmi
) 20 21 1075 1076 I-bmi
between 22 29 1077 1084 O
18 30 32 1085 1087 B-lower_bound
and 33 36 1088 1091 O
40 37 39 1092 1094 B-upper_bound
, 39 40 1094 1095 O
inclusive 41 50 1096 1105 O
, 50 51 1105 1106 O
for 52 55 1107 1110 O
patients 56 64 1111 1119 B-clinical_variable
≥18 65 68 1120 1123 O
years 69 74 1124 1129 I-lower_bound
old 75 78 1130 1133 O

Compliance 0 10 1134 1144 O
during 11 17 1145 1151 O
the 18 21 1152 1155 O
Run 22 25 1156 1159 B-clinical_variable
- 25 26 1159 1160 I-clinical_variable
in 26 28 1160 1162 I-clinical_variable
Period 29 35 1163 1169 I-clinical_variable
of 36 38 1170 1172 O
at 39 41 1173 1175 O
least 42 47 1176 1181 O
75 48 50 1182 1184 B-lower_bound
% 50 51 1184 1185 I-lower_bound
based 52 57 1186 1191 O
on 58 60 1192 1194 O
eDiary 61 67 1195 1201 O
entries 68 75 1202 1209 O
is 76 78 1210 1212 O
required 79 87 1213 1221 O
for 88 91 1222 1225 O
a 92 93 1226 1227 O
patient 94 101 1228 1235 O
to 102 104 1236 1238 O
qualify 105 112 1239 1246 O
for 113 116 1247 1250 O
randomization 117 130 1251 1264 O

Compliance 0 10 1265 1275 O
with 11 15 1276 1280 O
the 16 19 1281 1284 O
run 20 23 1285 1288 B-treatment
- 23 24 1288 1289 I-treatment
in 24 26 1289 1291 I-treatment
placebo 27 34 1292 1299 I-treatment
treatment 35 44 1300 1309 I-treatment
must 45 49 1310 1314 O
be 50 52 1315 1317 O
between 53 60 1318 1325 O
75 61 63 1326 1328 B-lower_bound
% 63 64 1328 1329 I-lower_bound
and 65 68 1330 1333 O
125 69 72 1334 1337 B-upper_bound
% 72 73 1337 1338 I-upper_bound

Diagnosed 0 9 1339 1348 O
with 10 14 1349 1353 O
asthma 15 21 1354 1360 B-chronic_disease
as 22 24 1361 1363 O
defined 25 32 1364 1371 O
by 33 35 1372 1374 O
the 36 39 1375 1378 O
NAEPP 40 45 1379 1384 O
3 46 47 1385 1386 O

Documented 0 10 1387 1397 O
total 11 16 1398 1403 B-clinical_variable
asthma 17 23 1404 1410 I-clinical_variable
symptom 24 31 1411 1418 I-clinical_variable
score 32 37 1419 1424 I-clinical_variable
of 38 40 1425 1427 O
≥1 41 43 1428 1430 O
for 44 47 1431 1434 O
at 48 50 1435 1437 O
least 51 56 1438 1443 O
2 57 58 1444 1445 B-lower_bound
days 59 63 1446 1450 I-lower_bound
during 64 70 1451 1457 O
the 71 74 1458 1461 O
Run 75 78 1462 1465 O
- 78 79 1465 1466 O
in 79 81 1466 1468 O
Period 82 88 1469 1475 O

Evidence 0 8 1476 1484 O
or 9 11 1485 1487 O
history 12 19 1488 1495 O
of 20 22 1496 1498 O
clinically 23 33 1499 1509 O
significant 34 45 1510 1521 O
disease 46 53 1522 1529 O
or 54 56 1530 1532 O
abnormality 57 68 1533 1544 O
including 69 78 1545 1554 O
congestive 79 89 1555 1565 B-chronic_disease
heart 90 95 1566 1571 I-chronic_disease
failure 96 103 1572 1579 I-chronic_disease
, 103 104 1579 1580 O
uncontrolled 105 117 1581 1593 B-chronic_disease
hypertension 118 130 1594 1606 I-chronic_disease
, 130 131 1606 1607 O
uncontrolled 132 144 1608 1620 O
coronary 145 153 1621 1629 B-chronic_disease
artery 154 160 1630 1636 I-chronic_disease
disease 161 168 1637 1644 I-chronic_disease
, 168 169 1644 1645 O
myocardial 170 180 1646 1656 B-chronic_disease
infarction 181 191 1657 1667 I-chronic_disease
, 191 192 1667 1668 O
or 193 195 1669 1671 O
cardiac 196 203 1672 1679 B-chronic_disease
dysrhythmia 204 215 1680 1691 I-chronic_disease

Exercise 0 8 1692 1700 B-chronic_disease
- 8 9 1700 1701 I-chronic_disease
induced 9 16 1701 1708 I-chronic_disease
asthma 17 23 1709 1715 I-chronic_disease
as 24 26 1716 1718 O
the 27 30 1719 1722 O
only 31 35 1723 1727 O
asthma 36 42 1728 1734 O
- 42 43 1734 1735 O
related 43 50 1735 1742 O
diagnosis 51 60 1743 1752 O

Female 0 6 1753 1759 B-gender
patients 7 15 1760 1768 I-gender
must 16 20 1769 1773 O
not 21 24 1774 1777 O
be 25 27 1778 1780 O
lactating 28 37 1781 1790 O
or 38 40 1791 1793 O
pregnant 41 49 1794 1802 B-pregnancy
at 50 52 1803 1805 O
screening 53 62 1806 1815 O

For 0 3 1816 1819 O
adolescent 4 14 1820 1830 O
patients 15 23 1831 1839 O
12 24 26 1840 1842 B-lower_bound
to 27 29 1843 1845 O
17 30 32 1846 1848 B-upper_bound
years 33 38 1849 1854 I-upper_bound
old 39 42 1855 1858 O
, 42 43 1858 1859 O
BMI 44 47 1860 1863 B-bmi
between 48 55 1864 1871 O
15 56 58 1872 1874 B-lower_bound
and 59 62 1875 1878 O
40 63 65 1879 1881 B-upper_bound
inclusive 66 75 1882 1891 O

Have 0 4 1892 1896 O
received 5 13 1897 1905 O
any 14 17 1906 1909 O
investigational 18 33 1910 1925 B-treatment
treatment 34 43 1926 1935 I-treatment
within 44 50 1936 1942 O
30 51 53 1943 1945 B-upper_bound
days 54 58 1946 1950 I-upper_bound
( 59 60 1951 1952 O
or 60 62 1952 1954 O
within 63 69 1955 1961 O
5 70 71 1962 1963 B-upper_bound
terminal 72 80 1964 1972 I-upper_bound
half 81 85 1973 1977 I-upper_bound
- 85 86 1977 1978 I-upper_bound
lives 86 91 1978 1983 I-upper_bound
of 92 94 1984 1986 O
the 95 98 1987 1990 O
investigational 99 114 1991 2006 B-treatment
drug 115 119 2007 2011 I-treatment
whichever 120 129 2012 2021 O
is 130 132 2022 2024 O
longer 133 139 2025 2031 O
) 139 140 2031 2032 O
of 141 143 2033 2035 O
the 144 147 2036 2039 O
screening 148 157 2040 2049 O
visit 158 163 2050 2055 O

History 0 7 2056 2063 O
of 8 10 2064 2066 O
alcohol 11 18 2067 2074 O
or 19 21 2075 2077 O
drug 22 26 2078 2082 O
abuse 27 32 2083 2088 O
within 33 39 2089 2095 O
the 40 43 2096 2099 O
last 44 48 2100 2104 B-upper_bound
6 49 50 2105 2106 I-upper_bound
months 51 57 2107 2113 I-upper_bound

Life 0 4 2114 2118 O
- 4 5 2118 2119 O
threatening 5 16 2119 2130 O
asthma 17 23 2131 2137 B-chronic_disease
, 23 24 2137 2138 O
defined 25 32 2139 2146 O
as 33 35 2147 2149 O
a 36 37 2150 2151 O
history 38 45 2152 2159 O
of 46 48 2160 2162 O
asthma 49 55 2163 2169 O
episode(s 56 65 2170 2179 O
) 65 66 2179 2180 O
requiring 67 76 2181 2190 O
intubation 77 87 2191 2201 B-treatment

Male 0 4 2202 2206 B-gender
patients 5 13 2207 2215 I-gender
and 14 17 2216 2219 O
male 18 22 2220 2224 B-gender
partners 23 31 2225 2233 I-gender
of 32 34 2234 2236 O
female 35 41 2237 2243 B-gender
patients 42 50 2244 2252 I-gender
( 51 52 2253 2254 O
WOCBP 52 57 2254 2259 O
) 57 58 2259 2260 O
must 59 63 2261 2265 O
commit 64 70 2266 2272 O
to 71 73 2273 2275 O
consistent 74 84 2276 2286 O
and 85 88 2287 2290 O
correct 89 96 2291 2298 O
use 97 100 2299 2302 O
of 101 103 2303 2305 O
an 104 106 2306 2308 O
acceptable 107 117 2309 2319 O
method 118 124 2320 2326 O
of 125 127 2327 2329 O
birth 128 133 2330 2335 O
control 134 141 2336 2343 O
( 142 143 2344 2345 O
at 143 145 2345 2347 O
the 146 149 2348 2351 O
Investigator 150 162 2352 2364 O
's 162 164 2364 2366 O
discretion 165 175 2367 2377 O
) 175 176 2377 2378 O
throughout 177 187 2379 2389 O
the 188 191 2390 2393 O
study 192 197 2394 2399 O

Moderate 0 8 2400 2408 O
to 9 11 2409 2411 O
severe 12 18 2412 2418 O
asthma 19 25 2419 2425 B-chronic_disease
with 26 30 2426 2430 O
a 31 32 2431 2432 O
pre 33 36 2433 2436 B-clinical_variable
- 36 37 2436 2437 I-clinical_variable
bronchodilator 37 51 2437 2451 I-clinical_variable
FEV1 52 56 2452 2456 I-clinical_variable
of 57 59 2457 2459 O
≥45 60 63 2460 2463 O
% 63 64 2463 2464 I-lower_bound
and 65 68 2465 2468 O
≤85 69 72 2469 2472 O
% 72 73 2472 2473 I-upper_bound
of 74 76 2474 2476 O
the 77 80 2477 2480 O
predicted 81 90 2481 2490 O
normal 91 97 2491 2497 O
value 98 103 2498 2503 O
during 104 110 2504 2510 O
measured 111 119 2511 2519 O
at 120 122 2520 2522 O
least 123 128 2523 2528 O
6 129 130 2529 2530 B-lower_bound
hours 131 136 2531 2536 I-lower_bound
after 137 142 2537 2542 I-lower_bound
short 143 148 2543 2548 B-treatment
- 148 149 2548 2549 I-treatment
acting 149 155 2549 2555 I-treatment
β 156 157 2556 2557 I-treatment
agonist 158 165 2558 2565 I-treatment
( 166 167 2566 2567 I-treatment
SABA 167 171 2567 2571 I-treatment
) 171 172 2571 2572 I-treatment

Monoclonal 0 10 2573 2583 B-treatment
antibodies 11 21 2584 2594 I-treatment
/ 21 22 2594 2595 O
Biologic 22 30 2595 2603 B-treatment
agents 31 37 2604 2610 I-treatment
which 38 43 2611 2616 O
may 44 47 2617 2620 O
affect 48 54 2621 2627 O
the 55 58 2628 2631 O
course 59 65 2632 2638 O
of 66 68 2639 2641 O
asthma 69 75 2642 2648 B-chronic_disease
( 76 77 2649 2650 O
such 77 81 2650 2654 O
as 82 84 2655 2657 O
mepolizumab 85 96 2658 2669 B-treatment
, 96 97 2669 2670 O
reslizumab 98 108 2671 2681 B-treatment
, 108 109 2681 2682 O
lebrikizumab 110 122 2683 2695 B-treatment
, 122 123 2695 2696 O
and 124 127 2697 2700 O
others 128 134 2701 2707 O
) 134 135 2707 2708 O

Once 0 4 2709 2713 O
- 4 5 2713 2714 O
a 5 6 2714 2715 O
- 6 7 2715 2716 O
day 7 10 2716 2719 O
controlled 11 21 2720 2730 O
- 21 22 2730 2731 O
release 22 29 2731 2738 O
forms 30 35 2739 2744 O
of 36 38 2745 2747 O
theophylline 39 51 2748 2760 B-treatment
: 51 52 2760 2761 O
36 53 55 2762 2764 O
hours 56 61 2765 2770 O

Oral 0 4 2771 2775 B-treatment
( 5 6 2776 2777 I-treatment
not 6 9 2777 2780 I-treatment
inhaled 10 17 2781 2788 I-treatment
) 17 18 2788 2789 I-treatment
SABAs 19 24 2790 2795 I-treatment
for 25 28 2796 2799 O
24 29 31 2800 2802 O
hours 32 37 2803 2808 O

Oral 0 4 2809 2813 B-treatment
corticosteroids 5 20 2814 2829 I-treatment
for 21 24 2830 2833 O
30 25 27 2834 2836 B-lower_bound
days 28 32 2837 2841 I-lower_bound

Oral 0 4 2842 2846 B-treatment
β 5 6 2847 2848 I-treatment
- 6 7 2848 2849 I-treatment
blockers 7 15 2849 2857 I-treatment

Patients 0 8 2858 2866 O
taking 9 15 2867 2873 O
medication(s 16 28 2874 2886 B-treatment
) 28 29 2886 2887 I-treatment
( 30 31 2888 2889 O
either 31 37 2889 2895 O
daily 38 43 2896 2901 O
or 44 46 2902 2904 O
as 47 49 2905 2907 O
needed 50 56 2908 2914 O
) 56 57 2914 2915 O
with 58 62 2916 2920 O
the 63 66 2921 2924 O
potential 67 76 2925 2934 O
to 77 79 2935 2937 O
affect 80 86 2938 2944 O
the 87 90 2945 2948 O
course 91 97 2949 2955 O
of 98 100 2956 2958 O
asthma 101 107 2959 2965 B-chronic_disease
or 108 110 2966 2968 O
to 111 113 2969 2971 O
interact 114 122 2972 2980 O
with 123 127 2981 2985 O
sympathomimetic 128 143 2986 3001 B-treatment
amines 144 150 3002 3008 I-treatment

Patients 0 8 3009 3017 O
who 9 12 3018 3021 O
required 13 21 3022 3030 O
systemic 22 30 3031 3039 B-treatment
corticosteroids 31 46 3040 3055 I-treatment
( 47 48 3056 3057 O
for 48 51 3057 3060 O
any 52 55 3061 3064 O
reason 56 62 3065 3071 O
) 62 63 3071 3072 O

Patients 0 8 3073 3081 O
with 9 13 3082 3086 O
hypersensitivity 14 30 3087 3103 O
to 31 33 3104 3106 O
any 34 37 3107 3110 O
sympathomimetic 38 53 3111 3126 B-allergy_name
drug 54 58 3127 3131 I-allergy_name
( 59 60 3132 3133 O
e.g. 60 64 3133 3137 O
, 64 65 3137 3138 O
formoterol 66 76 3139 3149 B-allergy_name
, 76 77 3149 3150 O
albuterol 78 87 3151 3160 B-allergy_name
/ 87 88 3160 3161 O
salbutamol 88 98 3161 3171 B-allergy_name
, 98 99 3171 3172 O
or 100 102 3173 3175 O
salmeterol 103 113 3176 3186 B-allergy_name
) 113 114 3186 3187 O
or 115 117 3188 3190 O
any 118 121 3191 3194 O
inhaled 122 129 3195 3202 B-allergy_name
, 129 130 3202 3203 O
intranasal 131 141 3204 3214 B-allergy_name
, 141 142 3214 3215 O
or 143 145 3216 3218 O
systemic 146 154 3219 3227 B-allergy_name
corticosteroid 155 169 3228 3242 I-allergy_name
therapy 170 177 3243 3250 I-allergy_name

Patients 0 8 3251 3259 O
with 9 13 3260 3264 O
well 14 18 3265 3269 O
- 18 19 3269 3270 O
controlled 19 29 3270 3280 O
hypertension 30 42 3281 3293 B-chronic_disease
, 42 43 3293 3294 O
diabetes 44 52 3295 3303 B-chronic_disease
or 53 55 3304 3306 O
hypercholesterolemia 56 76 3307 3327 B-chronic_disease
are 77 80 3328 3331 O
not 81 84 3332 3335 O
excluded 85 93 3336 3344 O
as 94 96 3345 3347 O
long 97 101 3348 3352 O
as 102 104 3353 3355 O
their 105 110 3356 3361 O
medication 111 121 3362 3372 B-treatment
does 122 126 3373 3377 O
not 127 130 3378 3381 O
interfere 131 140 3382 3391 O
with 141 145 3392 3396 O
the 146 149 3397 3400 O
study 150 155 3401 3406 O

Short 0 5 3407 3412 O
- 5 6 3412 3413 O
acting 6 12 3413 3419 O
forms 13 18 3420 3425 O
of 19 21 3426 3428 O
theophylline 22 34 3429 3441 B-treatment
: 34 35 3441 3442 O
12 36 38 3443 3445 O
hours 39 44 3446 3451 O

Stable 0 6 3452 3458 O
on 7 9 3459 3461 O
chronic 10 17 3462 3469 O
asthma 18 24 3470 3476 B-treatment
treatment 25 34 3477 3486 I-treatment
regimen 35 42 3487 3494 O
for 43 46 3495 3498 O
at 47 49 3499 3501 O
least 50 55 3502 3507 O
4 56 57 3508 3509 B-lower_bound
weeks 58 63 3510 3515 I-lower_bound
prior 64 69 3516 3521 I-lower_bound
to 70 72 3522 3524 O
enrollment 73 83 3525 3535 O

Strong 0 6 3536 3542 O
cytochrome 7 17 3543 3553 B-treatment
P450 18 22 3554 3558 I-treatment
3A4 23 26 3559 3562 I-treatment
inhibitors 27 37 3563 3573 I-treatment
( 38 39 3574 3575 O
e.g. 39 43 3575 3579 O
, 43 44 3579 3580 O
ritonavir 45 54 3581 3590 B-treatment
) 54 55 3590 3591 O

Twice 0 5 3592 3597 O
- 5 6 3597 3598 O
a 6 7 3598 3599 O
- 7 8 3599 3600 O
day 8 11 3600 3603 O
controlled 12 22 3604 3614 O
- 22 23 3614 3615 O
release 23 30 3615 3622 O
forms 31 36 3623 3628 O
of 37 39 3629 3631 O
theophylline 40 52 3632 3644 B-treatment
: 52 53 3644 3645 O
24 54 56 3646 3648 O
hours 57 62 3649 3654 O

Viral 0 5 3655 3660 B-chronic_disease
or 6 8 3661 3663 O
bacterial 9 18 3664 3673 B-chronic_disease
, 18 19 3673 3674 O
upper 20 25 3675 3680 B-chronic_disease
or 26 28 3681 3683 I-chronic_disease
lower 29 34 3684 3689 I-chronic_disease
respiratory 35 46 3690 3701 I-chronic_disease
tract 47 52 3702 3707 I-chronic_disease
infection 53 62 3708 3717 I-chronic_disease
or 63 65 3718 3720 O
sinus 66 71 3721 3726 B-chronic_disease
or 72 74 3727 3729 O
middle 75 81 3730 3736 B-bmi
ear 82 85 3737 3740 I-bmi
infection 86 95 3741 3750 I-bmi

Willing 0 7 3751 3758 O
to 8 10 3759 3761 O
discontinue 11 22 3762 3773 O
asthma 23 29 3774 3780 B-treatment
medications 30 41 3781 3792 I-treatment
( 42 43 3793 3794 O
ICS 43 46 3794 3797 B-treatment
and 47 50 3798 3801 O
LABAs 51 56 3802 3807 B-treatment
) 56 57 3807 3808 O
during 58 64 3809 3815 O
the 65 68 3816 3819 O
Run 69 72 3820 3823 O
- 72 73 3823 3824 O
in 73 75 3824 3826 O
Period 76 82 3827 3833 O
and 83 86 3834 3837 O
for 87 90 3838 3841 O
the 91 94 3842 3845 O
remainder 95 104 3846 3855 O
of 105 107 3856 3858 O
the 108 111 3859 3862 O
study 112 117 3863 3868 O

Women 0 5 3869 3874 B-gender
of 6 8 3875 3877 O
childbearing 9 21 3878 3890 O
potential 22 31 3891 3900 O
( 32 33 3901 3902 O
WOCBP 33 38 3902 3907 O
) 38 39 3907 3908 O

as 0 2 3909 3911 O
documented 3 13 3912 3922 O
by 14 16 3923 3925 O
a 17 18 3926 3927 O
negative 19 27 3928 3936 B-pregnancy
serum 28 33 3937 3942 I-pregnancy
pregnancy 34 43 3943 3952 I-pregnancy
test 44 48 3953 3957 O
with 49 53 3958 3962 O
a 54 55 3963 3964 O
minimum 56 63 3965 3972 O
sensitivity 64 75 3973 3984 O
of 76 78 3985 3987 O
25 79 81 3988 3990 B-lower_bound
IU 82 84 3991 3993 I-lower_bound
/ 84 85 3993 3994 I-lower_bound
L 85 86 3994 3995 I-lower_bound
or 87 89 3996 3998 O
equivalent 90 100 3999 4009 O
units 101 106 4010 4015 O
of 107 109 4016 4018 O
beta 110 114 4019 4023 B-clinical_variable
- 114 115 4023 4024 I-clinical_variable
human 115 120 4024 4029 I-clinical_variable
chorionic 121 130 4030 4039 I-clinical_variable
gonadotropin 131 143 4040 4052 I-clinical_variable
( 144 145 4053 4054 I-clinical_variable
β 145 146 4054 4055 I-clinical_variable
- 146 147 4055 4056 I-clinical_variable
hCG 147 150 4056 4059 I-clinical_variable
) 150 151 4059 4060 I-clinical_variable
at 152 154 4061 4063 O
screening 155 164 4064 4073 O

associated 0 10 4074 4084 O
with 11 15 4085 4089 O
hypercapnea 16 27 4090 4101 B-chronic_disease
, 27 28 4101 4102 O
respiratory 29 40 4103 4114 B-chronic_disease
arrest 41 47 4115 4121 I-chronic_disease
or 48 50 4122 4124 O
hypoxic 51 58 4125 4132 O
seizures 59 67 4133 4141 B-chronic_disease
, 67 68 4141 4142 O
asthma 69 75 4143 4149 B-chronic_disease
- 75 76 4149 4150 O
related 76 83 4150 4157 O
syncopal 84 92 4158 4166 O
episode(s 93 102 4167 4176 O
) 102 103 4176 4177 O

at 0 2 4178 4180 O
least 3 8 4181 4186 O
24 9 11 4187 4189 B-lower_bound
hours 12 17 4190 4195 I-lower_bound
after 18 23 4196 4201 I-lower_bound
the 24 27 4202 4205 O
last 28 32 4206 4210 O
dose 33 37 4211 4215 O
of 38 40 4216 4218 O
long 41 45 4219 4223 B-treatment
- 45 46 4223 4224 I-treatment
acting 46 52 4224 4230 I-treatment
β 53 54 4231 4232 I-treatment
agonist 55 62 4233 4240 I-treatment
( 63 64 4241 4242 I-treatment
LABA 64 68 4242 4246 I-treatment
) 68 69 4246 4247 I-treatment
at 70 72 4248 4250 O
the 73 76 4251 4254 O
screening 77 86 4255 4264 O
visit 87 92 4265 4270 O
( 93 94 4271 4272 O
Visit 94 99 4272 4277 O
1 100 101 4278 4279 O
) 101 102 4279 4280 O

female 0 6 4281 4287 B-gender
partners 7 15 4288 4296 O
( 16 17 4297 4298 O
WOCBP 17 22 4298 4303 O
) 22 23 4303 4304 O
of 24 26 4305 4307 O
male 27 31 4308 4312 B-gender
patients 32 40 4313 4321 I-gender
participating 41 54 4322 4335 O
in 55 57 4336 4338 O
the 58 61 4339 4342 O
study 62 67 4343 4348 O

for 0 3 4349 4352 O
30 4 6 4353 4355 B-upper_bound
days 7 11 4356 4360 I-upper_bound
after 12 17 4361 4366 I-upper_bound
study 18 23 4367 4372 B-treatment
drug 24 28 4373 4377 I-treatment
discontinuation 29 44 4378 4393 O

for 0 3 4394 4397 O
30 4 6 4398 4400 B-upper_bound
days 7 11 4401 4405 I-upper_bound
after 12 17 4406 4411 I-upper_bound
the 18 21 4412 4415 O
study 22 27 4416 4421 B-treatment
drug 28 32 4422 4426 I-treatment
discontinuation 33 48 4427 4442 O

historical 0 10 4443 4453 O
or 11 13 4454 4456 O
current 14 21 4457 4464 O
evidence 22 30 4465 4473 O
of 31 33 4474 4476 O
significant 34 45 4477 4488 O
hematologic 46 57 4489 4500 B-chronic_disease
, 57 58 4500 4501 O
hepatic 59 66 4502 4509 B-chronic_disease
, 66 67 4509 4510 O
neurologic 68 78 4511 4521 B-chronic_disease
, 78 79 4521 4522 O
psychiatric 80 91 4523 4534 B-chronic_disease
, 91 92 4534 4535 O
renal 93 98 4536 4541 B-chronic_disease
, 98 99 4541 4542 O
or 100 102 4543 4545 O
other 103 108 4546 4551 O
diseases 109 117 4552 4560 O
that 118 122 4561 4565 O
, 122 123 4565 4566 O
in 124 126 4567 4569 O
the 127 130 4570 4573 O
opinion 131 138 4574 4581 O
of 139 141 4582 4584 O
the 142 145 4585 4588 O
Investigator 146 158 4589 4601 O
, 158 159 4601 4602 O
would 160 165 4603 4608 O
put 166 169 4609 4612 O
the 170 173 4613 4616 O
patient 174 181 4617 4624 O
at 182 184 4625 4627 O
risk 185 189 4628 4632 O
through 190 197 4633 4640 O
study 198 203 4641 4646 O
participation 204 217 4647 4660 O

hospitalizations 0 16 4661 4677 B-treatment
within 17 23 4678 4684 O
the 24 27 4685 4688 O
past 28 32 4689 4693 O
year 33 37 4694 4698 O
or 38 40 4699 4701 O
during 41 47 4702 4708 O
the 48 51 4709 4712 O
Run 52 55 4713 4716 O
- 55 56 4716 4717 O
in 56 58 4717 4719 O
Period 59 65 4720 4726 O

in 0 2 4727 4729 O
accordance 3 13 4730 4740 O
with 14 18 4741 4745 O
the 19 22 4746 4749 O
BMI 23 26 4750 4753 B-bmi
range 27 32 4754 4759 O
typical 33 40 4760 4767 O
for 41 44 4768 4771 O
the 45 48 4772 4775 O
age 49 52 4776 4779 B-age

obstructive 0 11 4780 4791 B-chronic_disease
sleep 12 17 4792 4797 I-chronic_disease
apnea 18 23 4798 4803 I-chronic_disease
warranting 24 34 4804 4814 O
a 35 36 4815 4816 O
prescription 37 49 4817 4829 O
for 50 53 4830 4833 O
continuous 54 64 4834 4844 B-treatment
or 65 67 4845 4847 I-treatment
biphasic 68 76 4848 4856 I-treatment
positive 77 85 4857 4865 I-treatment
airway 86 92 4866 4872 I-treatment
pressure 93 101 4873 4881 I-treatment
( 102 103 4882 4883 I-treatment
CPAP 103 107 4883 4887 I-treatment
or 108 110 4888 4890 I-treatment
BiPAP 111 116 4891 4896 I-treatment
) 116 117 4896 4897 I-treatment

on 0 2 4898 4900 O
the 3 6 4901 4904 O
first 7 12 4905 4910 O
day 13 16 4911 4914 O
of 17 19 4915 4917 O
treatment 20 29 4918 4927 B-treatment
( 30 31 4928 4929 O
prior 31 36 4929 4934 O
to 37 39 4935 4937 O
randomization 40 53 4938 4951 O
at 54 56 4952 4954 O
Visit 57 62 4955 4960 O
2 63 64 4961 4962 O
) 64 65 4962 4963 O

patients 0 8 4964 4972 O
should 9 15 4973 4979 O
be 16 18 4980 4982 O
able 19 23 4983 4987 O
to 24 26 4988 4990 O
withhold 27 35 4991 4999 O
all 36 39 5000 5003 O
inhaled 40 47 5004 5011 O
SABAs 48 53 5012 5017 B-treatment
for 54 57 5018 5021 O
at 58 60 5022 5024 O
least 61 66 5025 5030 O
6 67 68 5031 5032 B-lower_bound
hours 69 74 5033 5038 I-lower_bound
prior 75 80 5039 5044 I-lower_bound
to 81 83 5045 5047 O
lung 84 88 5048 5052 O
function 89 97 5053 5061 O
assessments 98 109 5062 5073 O
on 110 112 5074 5076 O
study 113 118 5077 5082 O
visits 119 125 5083 5089 O

plans 0 5 5090 5095 O
to 6 8 5096 5098 O
receive 9 16 5099 5106 O
investigational 17 32 5107 5122 B-treatment
treatment 33 42 5123 5132 I-treatment
within 43 49 5133 5139 O
30 50 52 5140 5142 B-upper_bound
days 53 57 5143 5147 I-upper_bound
after 58 63 5148 5153 O
the 64 67 5154 5157 O
study 68 73 5158 5163 O
is 74 76 5164 5166 O
completed 77 86 5167 5176 O

≥12 0 3 5177 5180 O
and 4 7 5181 5184 O
≤75 8 11 5185 5188 O
years 12 17 5189 5194 I-upper_bound
of 18 20 5195 5197 O
age 21 24 5198 5201 B-age

≥15 0 3 5202 5205 O
% 3 4 5205 5206 I-lower_bound
and 5 8 5207 5210 O
≥ 9 10 5211 5212 O
0.20 11 15 5213 5217 B-lower_bound
L 16 17 5218 5219 I-lower_bound
reversibility 18 31 5220 5233 O
of 32 34 5234 5236 O
FEV1 35 39 5237 5241 B-clinical_variable
within 40 46 5242 5248 O
30 47 49 5249 5251 B-upper_bound
minutes 50 57 5252 5259 I-upper_bound
following 58 67 5260 5269 O
360 68 71 5270 5273 O
mcg 72 75 5274 5277 O
( 76 77 5278 5279 O
4 77 78 5279 5280 O
puffs 79 84 5281 5286 O
) 84 85 5286 5287 O
of 86 88 5288 5290 O
albuterol 89 98 5291 5300 B-treatment
( 99 100 5301 5302 O
400 100 103 5302 5305 O
mcg 104 107 5306 5309 O
salbutamol 108 118 5310 5320 B-treatment
) 118 119 5320 5321 O
inhalation 120 130 5322 5332 B-treatment
( 131 132 5333 5334 I-treatment
pMDI 132 136 5334 5338 I-treatment
) 136 137 5338 5339 I-treatment

